Nov. 14 at 5:22 PM
$OCGN
Never forget about the intrinsic value of this stock
Never forget that we have a treatment on phase 3 and showing good results
And all other treatments are same and those results regulated and under the supervision of FDA --> this is the real talk
Financial position is not bad we have warrants and they can secure cash runway until the submission of the first BLA --> think about it
Why I am still optimistic--> because of the trail results and these results comparing to other competitors on same stages--> I am not a pharmaceutical expert but official articles and PR its not a that rocket science
+ Never forget about the market value for these diseases and the market caps of similar biotechs
We are undervalued, I myself believe that this stock worth more
Thanks 🤍
